|
Volumn 25, Issue 3, 2001, Pages 145-152
|
The efficacy and safety of asthma medications during pregnancy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
BECLOMETASONE;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
THEOPHYLLINE;
ASTHMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONGENITAL MALFORMATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FETUS MORTALITY;
HUMAN;
LOW BIRTH WEIGHT;
PREECLAMPSIA;
PREGNANCY;
PREMATURITY;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
|
EID: 0034973810
PISSN: 01460005
EISSN: None
Source Type: Journal
DOI: 10.1053/sper.2001.24569 Document Type: Conference Paper |
Times cited : (64)
|
References (36)
|